JP2017502253A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502253A5
JP2017502253A5 JP2016521777A JP2016521777A JP2017502253A5 JP 2017502253 A5 JP2017502253 A5 JP 2017502253A5 JP 2016521777 A JP2016521777 A JP 2016521777A JP 2016521777 A JP2016521777 A JP 2016521777A JP 2017502253 A5 JP2017502253 A5 JP 2017502253A5
Authority
JP
Japan
Prior art keywords
antibody
ibs
vinculin
cdt
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016521777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017502253A (ja
JP6567509B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059957 external-priority patent/WO2015054529A1/en
Publication of JP2017502253A publication Critical patent/JP2017502253A/ja
Publication of JP2017502253A5 publication Critical patent/JP2017502253A5/ja
Application granted granted Critical
Publication of JP6567509B2 publication Critical patent/JP6567509B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016521777A 2013-10-09 2014-10-09 過敏性腸症候および炎症性腸疾患の診断および治療 Active JP6567509B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361888658P 2013-10-09 2013-10-09
US61/888,658 2013-10-09
PCT/US2014/059957 WO2015054529A1 (en) 2013-10-09 2014-10-09 Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease

Publications (3)

Publication Number Publication Date
JP2017502253A JP2017502253A (ja) 2017-01-19
JP2017502253A5 true JP2017502253A5 (enExample) 2017-11-16
JP6567509B2 JP6567509B2 (ja) 2019-08-28

Family

ID=52813648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016521777A Active JP6567509B2 (ja) 2013-10-09 2014-10-09 過敏性腸症候および炎症性腸疾患の診断および治療

Country Status (19)

Country Link
US (2) US9851361B2 (enExample)
EP (1) EP3054977B1 (enExample)
JP (1) JP6567509B2 (enExample)
KR (1) KR102259588B1 (enExample)
CN (1) CN105744956B (enExample)
AU (2) AU2014331841B2 (enExample)
BR (1) BR112016007474A2 (enExample)
CA (1) CA2923651C (enExample)
CL (1) CL2016000820A1 (enExample)
ES (1) ES2892905T3 (enExample)
IL (1) IL244971B2 (enExample)
MX (1) MX383423B (enExample)
NZ (1) NZ717633A (enExample)
PE (1) PE20160882A1 (enExample)
PL (1) PL3054977T3 (enExample)
PT (1) PT3054977T (enExample)
RU (1) RU2683781C2 (enExample)
SG (1) SG11201601733VA (enExample)
WO (1) WO2015054529A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11693009B2 (en) 2009-02-11 2023-07-04 Cedars-Sinai Medical Center Methods for detecting post-infectious irritable bowel syndrome
MX348670B (es) 2009-02-11 2017-06-23 Cedars Sinai Medical Center Anticuerpo contra toxina de distensión citoletal de campylobacter jejuni.
KR102203568B1 (ko) 2012-09-17 2021-01-15 세다르스-신나이 메디칼 센터 장 및 방광의 운동 장애 및 섬유근육통의 진단 및 치료
CA2923651C (en) 2013-10-09 2023-03-14 Cedars-Sinai Medical Center Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
AU2015330872B2 (en) 2014-10-09 2021-04-22 Cedars-Sinai Medical Center Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
CN106053827A (zh) * 2016-05-17 2016-10-26 上海凯璟生物科技有限公司 一种肠易激综合症标志物Vinculin抗体检测试剂盒及其制备方法
CN105784989A (zh) * 2016-05-17 2016-07-20 上海凯璟生物科技有限公司 一种肠易激综合症标志物CdtB抗体检测试剂盒及其制备方法
CN109476698B (zh) * 2016-05-20 2023-10-17 西达-赛奈医疗中心 基于基因的炎性肠病诊断
AU2018212924A1 (en) 2017-01-30 2019-07-04 Cedars-Sinai Medical Center Diagnosis of scleroderma
RU2763258C1 (ru) * 2020-07-13 2021-12-28 Евгения Николаевна Воронина Способ дифференциальной диагностики воспалительных заболеваний кишечника у детей по комплексу клинико-анамнестических, лабораторных и инструментальных критериев

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691151A (en) * 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
FR2806805A1 (fr) 2000-03-22 2001-09-28 Centre Nat Rech Scient SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS
US20040018528A1 (en) * 2002-05-17 2004-01-29 Sugen, Inc. Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
EP1578364A4 (en) 2002-09-16 2011-06-08 Genentech Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF ILLNESSES OF THE IMMUNE SYSTEM
US7595386B2 (en) 2003-01-24 2009-09-29 William Beaumont Hospital Methods and compositions for heat activated gene therapy using cytolethal distending toxin
JP2006522817A (ja) * 2003-04-08 2006-10-05 プロジェニックス ファーマシューティカルズ,インコーポレーテッド 過敏性腸症候群を処置するための末梢オピオイドアンタゴニスト、特にメチルナルトレキソンの使用
US20060094056A1 (en) * 2003-09-15 2006-05-04 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases
EP1698698B1 (en) 2003-12-05 2014-02-12 Fuso Pharmaceutical Industries, Ltd. Cytolethal distending toxin genes as targets for the detection of campylobacter bacteria
US8148067B2 (en) 2006-11-09 2012-04-03 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
ES2391792T3 (es) 2007-12-20 2012-11-29 Index Diagnostics Ab (Publ) Método para la diferenciación de EII y SII y la distinción adicional entre tipos patológicos de EII
WO2010060098A1 (en) 2008-11-24 2010-05-27 Cedars-Sinai Medical Center Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof
MX348670B (es) 2009-02-11 2017-06-23 Cedars Sinai Medical Center Anticuerpo contra toxina de distensión citoletal de campylobacter jejuni.
US20110294726A1 (en) 2009-02-11 2011-12-01 Cedars-Sinai Medical Center Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
FR2942541A1 (fr) 2009-02-25 2010-08-27 Assist Publ Hopitaux De Paris Procede de diagnostic d'une vascularite
RU2397178C1 (ru) * 2009-02-27 2010-08-20 Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса
IT1400989B1 (it) 2010-07-13 2013-07-05 Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale.
GB201017520D0 (en) 2010-10-15 2010-12-01 Sense Proteomic Ltd Biomarkers
KR102203568B1 (ko) 2012-09-17 2021-01-15 세다르스-신나이 메디칼 센터 장 및 방광의 운동 장애 및 섬유근육통의 진단 및 치료
CA2923651C (en) 2013-10-09 2023-03-14 Cedars-Sinai Medical Center Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
AU2015330872B2 (en) 2014-10-09 2021-04-22 Cedars-Sinai Medical Center Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
CN106091069A (zh) 2016-06-15 2016-11-09 安徽省绿巨人环境技术有限公司 一种废水再利用装置
AU2018212924A1 (en) 2017-01-30 2019-07-04 Cedars-Sinai Medical Center Diagnosis of scleroderma

Similar Documents

Publication Publication Date Title
EP3978927A2 (en) Methods and reagents for diagnosis of sars-cov-2 infection
Lee Procalcitonin as a biomarker of infectious diseases
JP2010514805A5 (enExample)
RU2016116766A (ru) Диагностика и лечение синдрома раздраженного кишечника и воспалительного заболевания кишечника
JP2011516038A5 (enExample)
US10114028B2 (en) Biomarkers for pneumonia and acute decompensated heart failure
JP2017524130A5 (enExample)
JP2016105097A5 (enExample)
CN102395887A (zh) 用于检测降钙素原的免疫测定法
DK2904403T3 (en) PROCEDURE FOR DIAGNOSTICATION OR MONITORING OF Kidney Function or Diagnosis of Kidney Function
US11598772B2 (en) Method and products for the diagnosis of a seafood allergy
EP3320341A1 (en) Prognosis and monitoring of membranous nephropathy based on the analysis of pla2r1 epitope profile and spreading
JP2017531801A5 (enExample)
TW201231670A (en) A kit for examining plasma or serum antibody titers against periodontal pathogens
JP2018515071A5 (enExample)
JP6609570B2 (ja) がんを検出するための方法およびバイオマーカー
JP2010502192A (ja) Borisアイソフォーム並びに疾患を検出及び治療する方法
ES2793001T3 (es) Marcadores diagnósticos de inmunosenescencia y métodos para determinar la susceptibilidad a las infecciones nosocomiales
JP2011516037A5 (enExample)
Kim et al. A one-step immunoassay based on switching peptides for diagnosis of porcine epidemic diarrhea virus (PEDV) using screened Fv-antibodies
WO2021045224A1 (ja) がん免疫療法等における免疫関連有害事象の予測
WO2012061281A1 (en) Diagnostic assays and methods of use for detection of filarial infection
CN113366012A (zh) 幽门螺杆菌菌株的鉴定方法及鉴定试剂盒
JP2019050736A (ja) 血管炎の診断用バイオマーカー
JP6312054B2 (ja) 間質性肺炎のバイオマーカー